Literature DB >> 18996907

Risk reducing mastectomy: outcomes in 10 European centres.

D G R Evans1, A D Baildam, E Anderson, A Brain, A Shenton, H F A Vasen, D Eccles, A Lucassen, G Pichert, H Hamed, P Moller, L Maehle, P J Morrison, D Stoppat-Lyonnet, H Gregory, E Smyth, D Niederacher, C Nestle-Krämling, J Campbell, P Hopwood, F Lalloo, A Howell.   

Abstract

BACKGROUND: Increasingly women at high risk of breast cancer are opting for risk reducing surgery. The aim of this study was to assess the effectiveness of this approach in women at high risk in both carriers and non-carriers of BRCA1/2.
METHODS: Data from 10 European centres that offer a genetic counselling and screening service to women at risk were obtained prospectively from 1995. Breast cancer risks were estimated from life tables and a control group of women at risk who did not undergo surgery.
RESULTS: The combined centres have data on 550 women who have undergone risk reducing mastectomy with greater than 3334 women years of follow-up. Operations were carried out on women with lifetime risks of 25-80%, with an average expected incidence rate of 1% per year. No breast cancers have occurred in this cohort in the "at risk" unaffected breast, whereas >34 would have been expected. A high rate (2-3.6%) of occult disease was identified in the at risk breast at the time of surgery.
INTERPRETATION: We conclude that risk reducing surgery is highly effective.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18996907     DOI: 10.1136/jmg.2008.062232

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  29 in total

Review 1.  Oncological safety of prophylactic breast surgery: skin-sparing and nipple-sparing versus total mastectomy.

Authors:  Victorien M T van Verschuer; Marike C Maijers; Carolien H M van Deurzen; Linetta B Koppert
Journal:  Gland Surg       Date:  2015-12

Review 2.  The evolution of cancer surgery and future perspectives.

Authors:  Lynda Wyld; Riccardo A Audisio; Graeme J Poston
Journal:  Nat Rev Clin Oncol       Date:  2014-11-11       Impact factor: 66.675

3.  Interdisciplinary GoR level III Guidelines for the Diagnosis, Therapy and Follow-up Care of Breast Cancer: Short version - AWMF Registry No.: 032-045OL AWMF-Register-Nummer: 032-045OL - Kurzversion 3.0, Juli 2012.

Authors:  R Kreienberg; U-S Albert; M Follmann; I B Kopp; T Kühn; A Wöckel
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-06       Impact factor: 2.915

4.  Predictors of genetic testing uptake in newly diagnosed breast cancer patients.

Authors:  Mary K Ladd; Beth N Peshkin; Claudine Isaacs; Gillian Hooker; Shawna Willey; Heiddis Valdimarsdottir; Tiffani DeMarco; Suzanne O'Neill; Savannah Binion; Marc D Schwartz
Journal:  J Surg Oncol       Date:  2020-04-28       Impact factor: 3.454

5.  Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.

Authors:  Susan M Domchek; Tara M Friebel; Christian F Singer; D Gareth Evans; Henry T Lynch; Claudine Isaacs; Judy E Garber; Susan L Neuhausen; Ellen Matloff; Rosalind Eeles; Gabriella Pichert; Laura Van t'veer; Nadine Tung; Jeffrey N Weitzel; Fergus J Couch; Wendy S Rubinstein; Patricia A Ganz; Mary B Daly; Olufunmilayo I Olopade; Gail Tomlinson; Joellen Schildkraut; Joanne L Blum; Timothy R Rebbeck
Journal:  JAMA       Date:  2010-09-01       Impact factor: 56.272

6.  Looking different, feeling different: women's reactions to risk-reducing breast and ovarian surgery.

Authors:  Nina Hallowell; Brandi Baylock; Louise Heiniger; Phyllis N Butow; Deepa Patel; Bettina Meiser; Christobel Saunders; Melanie A Price
Journal:  Fam Cancer       Date:  2012-06       Impact factor: 2.375

Review 7.  Genetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting.

Authors:  Tuya Pal; Susan T Vadaparampil
Journal:  Cancer Control       Date:  2012-10       Impact factor: 3.302

8.  High penetrances of BRCA1 and BRCA2 mutations confirmed in a prospective series.

Authors:  Pål Møller; Lovise Mæhle; Lars F Engebretsen; Trond Ludvigsen; Christoffer Jonsrud; Jaran Apold; Anita Vabø; Neal Clark
Journal:  Hered Cancer Clin Pract       Date:  2010-01-19       Impact factor: 2.857

9.  A clinical perspective on ethical arguments around prenatal diagnosis and preimplantation genetic diagnosis for later onset inherited cancer predispositions.

Authors:  Tara Clancy
Journal:  Fam Cancer       Date:  2009-07-31       Impact factor: 2.375

Review 10.  Challenging and complex decisions in the management of the BRCA mutation carrier.

Authors:  Daniela L Stan; Lynne T Shuster; Myra J Wick; Casey L Swanson; Sandhya Pruthi; Jamie N Bakkum-Gamez
Journal:  J Womens Health (Larchmt)       Date:  2013-08-29       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.